product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Human E-Cadherin Antibody
catalog :
MAB1838-100
quantity :
100 ug (also 25 ug, 500 ug)
price :
519 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
180215
reactivity :
human, mouse
application :
western blot, immunohistochemistry, immunocytochemistry, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
citations: 29
Reference
Rossi V, Hochkoeppler A, Govoni M, Di Stefano G. Lactate-Induced HBEGF Shedding and EGFR Activation: Paving the Way to a New Anticancer Therapeutic Opportunity. Cells. 2024;13: pubmed publisher
Sprague J, Schille T, Allert S, Tr xfc mper V, Lier A, Gro xdf mann P, et al. Candida albicans translocation through the intestinal epithelial barrier is promoted by fungal zinc acquisition and limited by NFκB-mediated barrier protection. PLoS Pathog. 2024;20:e1012031 pubmed publisher
Khadim R, Vadivelu R, Utami T, Torizal F, Nishikawa M, Sakai Y. Integrating Oxygen and 3D Cell Culture System: A Simple Tool to Elucidate the Cell Fate Decision of hiPSCs. Int J Mol Sci. 2022;23: pubmed publisher
Rada M, Tsamchoe M, Kapelanski Lamoureux A, Hassan N, Bloom J, Petrillo S, et al. Cancer Cells Promote Phenotypic Alterations in Hepatocytes at the Edge of Cancer Cell Nests to Facilitate Vessel Co-Option Establishment in Colorectal Cancer Liver Metastases. Cancers (Basel). 2022;14: pubmed publisher
Rada M, Kapelanski Lamoureux A, Petrillo S, Tabari xe8 s S, SIEGEL P, Reynolds A, et al. Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases. Commun Biol. 2021;4:950 pubmed publisher
Goudsmit C, da Veiga Leprevost F, Basrur V, Peters L, Nesvizhskii A, Walline H. Differences in Extracellular Vesicle Protein Cargo Are Dependent on Head and Neck Squamous Cell Carcinoma Cell of Origin and Human Papillomavirus Status. Cancers (Basel). 2021;13: pubmed publisher
Chen Y, Tristan C, Chen L, Jovanovic V, Malley C, Chu P, et al. A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells. Nat Methods. 2021;18:528-541 pubmed publisher
Barkovskaya A, Goodwin C, Seip K, Hilmarsdottir B, Pettersen S, Stalnecker C, et al. Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen. Mol Oncol. 2021;15:2026-2045 pubmed publisher
Hu X, Villodre E, Larson R, Rahal O, Wang X, Gong Y, et al. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Commun Biol. 2021;4:72 pubmed publisher
Fan Y, Wang K. miR‑205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4. Mol Med Rep. 2020;22:633-642 pubmed publisher
An S, Raju I, Surenkhuu B, Kwon J, Gulati S, Karaman M, et al. Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies. Ocul Surf. 2019;: pubmed publisher
Casado Medrano V, Barrio Real L, Wang A, Cooke M, Lopez Haber C, Kazanietz M. Distinctive requirement of PKCε in the control of Rho GTPases in epithelial and mesenchymally transformed lung cancer cells. Oncogene. 2019;: pubmed publisher
Vanneste M, Huang Q, Li M, Moose D, Zhao L, STAMNES M, et al. High content screening identifies monensin as an EMT-selective cytotoxic compound. Sci Rep. 2019;9:1200 pubmed publisher
Shibata S, Hayashi R, Okubo T, Kudo Y, Katayama T, Ishikawa Y, et al. Selective Laminin-Directed Differentiation of Human Induced Pluripotent Stem Cells into Distinct Ocular Lineages. Cell Rep. 2018;25:1668-1679.e5 pubmed publisher
Zeng S, Zhu B, Zeng J, Wu W, Jiang C. Zeylenone represses the progress of human prostate cancer by downregulating the Wnt/β‑catenin pathway. Mol Med Rep. 2018;18:5572-5578 pubmed publisher
Roux L, Petit I, Domart R, Concordet J, Qu J, Zhou H, et al. Modeling of Aniridia-Related Keratopathy by CRISPR/Cas9 Genome Editing of Human Limbal Epithelial Cells and Rescue by Recombinant PAX6 Protein. Stem Cells. 2018;36:1421-1429 pubmed publisher
Ye Q, Lei L, Shao L, Shi J, Jia J, Tong X. MicroRNA‑141 inhibits epithelial‑mesenchymal transition, and ovarian cancer cell migration and invasion. Mol Med Rep. 2017;16:6743-6749 pubmed publisher
Piyush T, Rhodes J, Yu L. MUC1 O-glycosylation contributes to anoikis resistance in epithelial cancer cells. Cell Death Discov. 2017;3:17044 pubmed publisher
Mak S, Alev C, Nagai H, Wrabel A, Matsuoka Y, Honda A, et al. Characterization of the finch embryo supports evolutionary conservation of the naive stage of development in amniotes. elife. 2015;4:e07178 pubmed publisher
Zhao Q, Piyush T, Chen C, Hollingsworth M, Hilkens J, Rhodes J, et al. MUC1 extracellular domain confers resistance of epithelial cancer cells to anoikis. Cell Death Dis. 2014;5:e1438 pubmed publisher
Panzarini E, Inguscio V, Fimia G, Dini L. Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of Damage-Associated Molecular Patterns (DAMPs) in human HeLa cells. PLoS ONE. 2014;9:e105778 pubmed publisher
Izumi K, Fang L, Mizokami A, Namiki M, Li L, Lin W, et al. Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation. EMBO Mol Med. 2013;5:1383-401 pubmed publisher
Wang X, Lee S, Xia S, Jiang Q, Luo J, Li L, et al. Endothelial cells enhance prostate cancer metastasis via IL-6?androgen receptor?TGF-??MMP-9 signals. Mol Cancer Ther. 2013;12:1026-37 pubmed publisher
Hashimoto T, Soeno Y, Maeda G, Taya Y, Aoba T, Nasu M, et al. Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch. PLoS ONE. 2012;7:e47899 pubmed publisher
Maupin K, Sinha A, Eugster E, Miller J, Ross J, Paulino V, et al. Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems. PLoS ONE. 2010;5:e13002 pubmed publisher
Zhao Q, Barclay M, Hilkens J, Guo X, Barrow H, Rhodes J, et al. Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Mol Cancer. 2010;9:154 pubmed publisher
Franciszkiewicz K, Le Floc h A, Jalil A, Vigant F, Robert T, Vergnon I, et al. Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention. Cancer Res. 2009;69:6249-55 pubmed publisher
Wanami L, Chen H, Peiro S, Garcia de Herreros A, Bachelder R. Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: implications for tumor progression. Exp Cell Res. 2008;314:2448-53 pubmed publisher
Miyazawa J, Mitoro A, Kawashiri S, Chada K, Imai K. Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res. 2004;64:2024-9 pubmed
product information
brand :
R&D Systems
master code :
MAB1838
SKU :
MAB1838-100
product name :
Human E-Cadherin Antibody
unit size :
100 ug (also 25 ug, 500 ug)
seo description :
The Human E-Cadherin Antibody from R&D Systems is a mouse monoclonal antibody to E-Cadherin. This antibody reacts with human,mouse. The Human E-Cadherin Antibody has been validated for the following applications: Immunohistochemistry,Immunocytochemistry,Western Blot,Flow Cytometry,Simple Western,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen.
target :
E-Cadherin
category :
Primary Antibodies
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 ╡m filtered solution in PBS.
clonality :
Monoclonal
clone :
180215
concentration :
LYOPH
conjugate :
Unconjugated
dilution :
Western Blot 0.5 ug/mL, Simple Western 5 ug/mL, Immunohistochemistry 2-25 ug/mL
host :
Mouse
immunogen :
Mouse myeloma cell line NS0-derived recombinant human E-Cadherin, Asp155-Ile707, Accession # P12830
isotype :
IgG2b
purity :
Protein A or G purified from hybridoma culture supernatant
species :
Human,Mouse
specificity :
Detects human E-Cadherin in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) Cadherin-8, rhCadherin-17, recombinant mouse E-Cadherin, rhN-Cadherin, rhP-Cadherin, or rhVE-Cadherin is observed.
gene symbol :
CDH1
top caption :
Detection of Human E-Cadherin antibody by Western Blot.
accessionNumbers :
P12830
applications :
Immunohistochemistry,Flow Cytometry,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,Simple Western,Immunocytochemistry
USD :
519 USD
alt names :
Arc-1, CAD1, cadherin 1, E-cadherin (epithelial), cadherin 1, type 1, E-cadherin (epithelial), cadherin-1, calcium-dependent adhesion protein, epithelial, CAM 120/80, CD324, CD324 antigen, CDH1, CDHE, cell-CAM 120/80, Cell-CAM120/80, ECAD, E-cadherin, ECadherin, Epithelial cadherin, LCAM, L-CAM, UVOE-Cadherin, uvomorulin
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 6 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.